Severe Graves' disease‐associated orbitopathy: A rare case of frontal bone hemangioma
Abstract Graves' orbitopathy might be severe, requiring treatment with high‐dose glucocorticoids. A lytic bone lesion, malignant lesions, and diseases resulting from bone remodeling processes (eg, Paget's disease) must be excluded by markers and imagery. Outcomes of high‐dose glucocorticoi...
Main Authors: | Ahmad Alamri, Daphné Pauchet, André Balaton, Constance Oriez, Olivier Dupuy, Adrien Ben Hamou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-02-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.3638 |
Similar Items
-
Puls-therapy with metilprednisolon in Grave's orbitopathy
Published: (2012-12-01) -
Clinical utility of TSH receptor antibody levels in Graves’ orbitopathy: a comparison of two TSH receptor antibody immunoassays
by: Gabriela A. Bluszcz, et al.
Published: (2018-12-01) -
Current Knowledge on Graves’ Orbitopathy
by: Katarzyna Gontarz-Nowak, et al.
Published: (2021-12-01) -
Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature
by: Neeraja Boddu, et al.
Published: (2017-07-01) -
Clinical and imaging evaluation of the response to intravenous steroids in patients with Graves’ orbitopathy and analysis on who requires additional therapy
by: Tsirouki T, et al.
Published: (2016-11-01)